Voice Articles
Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations
Multiple myeloma is a plasma cell neoplasm and the second most common hematologic malignancy in the United States, although overall incidence rates are relatively low at approximately 32,000 annually. The overall five-year survival rate is 52%, and most people are diagnosed with the disease in later stages.